{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:02:13Z","timestamp":1789671733845,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Progressive familial intrahepatic cholestasis (PFIC) is a group of autosomal recessive disorders characterized by impaired bile formation and secretion, frequently progressing to cirrhosis and end-stage liver disease. This study characterized the genotypic and phenotypic spectrum of PFIC in a pediatric cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study with prospective enrollment of additional cases and longitudinal follow-up included 17 children with molecularly confirmed PFIC managed at Alexandria University Children\u2019s Hospital between 2017 and 2026. Clinical, biochemical, histopathological, genetic, therapeutic, and outcome data were reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Three, ten, two, and two patients had PFIC types 1, 2, 3, and 8, respectively, with pathogenic variants in\n                      <jats:italic>ATP8B1<\/jats:italic>\n                      ,\n                      <jats:italic>ABCB11<\/jats:italic>\n                      ,\n                      <jats:italic>ABCB4<\/jats:italic>\n                      , and\n                      <jats:italic>KIF12<\/jats:italic>\n                      , including four novel variants. PFIC types 1 and 2 presented with early-onset low gamma-glutamyl transferase (GGT) cholestasis and severe pruritus; five patients underwent biliary diversion. PFIC type 2 showed more severe liver disease than PFIC type 1. PFIC types 3 and 8 presented later with atypical non-icteric presentations with hepatosplenomegaly and elevated GGT without classical histopathological cholestasis in three cases. Three patients underwent successful liver transplantation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PFIC exhibits marked phenotypic heterogeneity. Recognition of atypical and non-icteric presentations broadens its clinical spectrum and highlights the importance of comprehensive genetic testing for accurate diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>impact statement<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>The study identifies and characterizes novel variants in the ABCB11, ABCB4, and KIF12 genes within an Egyptian pediatric cohort, expanding the known mutational spectrum of the disease.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The study reported unusual presentation for PFIC type 3 and 8 with rapid fibrotic progression even in the absence of clinical jaundice or histological evidence of bile plugs challenging the diagnostic reliance on overt cholestasis as the primary clinical marker for PFIC.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-026-05422-5","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:04:46Z","timestamp":1789668286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel genetic variants and atypical phenotypes in pediatric progressive familial intrahepatic cholestasis"],"prefix":"10.1038","author":[{"given":"Manal","family":"Abdel Gawad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aml","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Abdel-Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Mastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8493-9309","authenticated-orcid":false,"given":"Basant","family":"Elbanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"5422_CR1","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.dld.2019.04.013","volume":"51","author":"G Vitale","year":"2019","unstructured":"Vitale, G., Gitto, S., Vukotic, R., Raimondi, F. & Andreone, P. Familial intrahepatic cholestasis: New and wide perspectives. Digestive Liver Dis. 51, 922\u201333, https:\/\/doi.org\/10.1016\/j.dld.2019.04.013 (2019).","journal-title":"Digestive Liver Dis."},{"key":"5422_CR2","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.3390\/cancers14143421","volume":"14","author":"G Vitale","year":"2022","unstructured":"Vitale, G. et al. Genetics in familial intrahepatic cholestasis: clinical patterns and development of liver and biliary cancers: a review of the literature. Cancers (Basel) 14, 3421, https:\/\/doi.org\/10.3390\/cancers14143421 (2022).","journal-title":"Cancers (Basel)"},{"key":"5422_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cld.2018.06.003","volume":"22","author":"LN Bull","year":"2018","unstructured":"Bull, L. N. & Thompson, R. J. Progressive familial intrahepatic cholestasis. Clin. Liver Dis. 22, 657\u201369, https:\/\/doi.org\/10.1016\/j.cld.2018.06.003 (2018).","journal-title":"Clin. Liver Dis."},{"key":"5422_CR4","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/liv.15200","volume":"42","author":"E Pfister","year":"2022","unstructured":"Pfister, E. et al. Extrahepatic manifestations of progressive familial intrahepatic cholestasis syndromes: Presentation of a case series and literature review. Liver Int. 42, 1084\u201396, https:\/\/doi.org\/10.1111\/liv.15200 (2022).","journal-title":"Liver Int."},{"key":"5422_CR5","unstructured":"https:\/\/www.omim.org\/. accessed 24 July 2025. Home \u2013 OMIM."},{"key":"5422_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21608\/alexpo.2025.357364.2076","volume":"7","author":"MM Abdelgawad","year":"2025","unstructured":"Abdelgawad, M. M. & Mahfouz, A. Clinical and laboratory profile of children with progressive familial intrahepatic cholestasis attending liver clinic In Alexandria University Children\u2019s Hospital. ALEXMED ePosters 7, 26\u20137, https:\/\/doi.org\/10.21608\/alexpo.2025.357364.2076 (2025).","journal-title":"ALEXMED ePosters"},{"key":"5422_CR7","unstructured":"Fryar, C. D., Carroll, M. D., Gu, Q., Afful, J. & Ogden, C. L. Anthropometric reference data for children and adults: United States, 2015-2018. Vital Health Stat 3, Analytical and epidemiological studies. 36, 1\u201344 (2021)."},{"key":"5422_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/PAS.0b013e318212ec87","volume":"35","author":"K Evason","year":"2011","unstructured":"Evason, K. et al. Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2). Am. J. Surgical Pathol. 35, 687\u201396, https:\/\/doi.org\/10.1097\/PAS.0b013e318212ec87 (2011).","journal-title":"Am. J. Surgical Pathol."},{"key":"5422_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","volume":"13","author":"PJ Scheuer","year":"1991","unstructured":"Scheuer, P. J. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 13, 372\u20134, https:\/\/doi.org\/10.1016\/0168-8278(91)90084-O (1991).","journal-title":"J. Hepatol."},{"key":"5422_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology. Genet. Med. 17, 405\u201324, https:\/\/doi.org\/10.1038\/gim.2015.30 (2015).","journal-title":"Genet. Med."},{"key":"5422_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/cge.13848","volume":"98","author":"GH Seo","year":"2020","unstructured":"Seo, G. H. et al. Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE. Clin. Genet 98, 562\u201370, https:\/\/doi.org\/10.1111\/cge.13848 (2020).","journal-title":"Clin. Genet"},{"key":"5422_CR12","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42, D980\u20135, https:\/\/doi.org\/10.1093\/nar\/gkt1113 (2014).","journal-title":"Nucleic Acids Res"},{"key":"5422_CR13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u201343, https:\/\/doi.org\/10.1038\/s41586-020-2308-7 (2020).","journal-title":"Nature"},{"key":"5422_CR14","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/S0140-6736(21)01256-3","volume":"398","author":"E Gonzales","year":"2021","unstructured":"Gonzales, E. et al. Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study.  Lancet 398, 1581\u201392, https:\/\/doi.org\/10.1016\/S0140-6736(21)01256-3 (2021).","journal-title":"Lancet"},{"key":"5422_CR15","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/hep.23539","volume":"51","author":"A Davit-Spraul","year":"2010","unstructured":"Davit-Spraul, A. et al. Atp8b1 and Abcb11 aAnalysis in 62 children with normal Gamma-Glutamyl Transferase Progressive Familial Intrahepatic Cholestasis (PFIC): phenotypic differences between Pfic1 and Pfic2 and natural history. Hepatol 51, 1645\u201355, https:\/\/doi.org\/10.1002\/hep.23539 (2010).","journal-title":"Hepatol"},{"key":"5422_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jceh.2016.05.003","volume":"6","author":"S Agarwal","year":"2016","unstructured":"Agarwal, S. et al. Progressive Familial Intrahepatic Cholestasis (PFIC) in Indian Children: clinical spectrum and outcome. J. Clin. Exp. Hepatol. 6, 203\u20138, https:\/\/doi.org\/10.1016\/j.jceh.2016.05.003 (2016).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"5422_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/cge.70004","volume":"109","author":"NM Elkoofy","year":"2026","unstructured":"Elkoofy, N. M., El-Shabrawi, M. H. & Elmonem, M. A. Clinical and genetic spectra of progressive familial intrahepatic cholestasis with normal GGT: 31 pediatric patients and 16 novel variants. Clin. Genet 109, 141\u20138 (2026).","journal-title":"Clin. Genet"},{"key":"5422_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101309","volume":"7","author":"A Di Giorgio","year":"2025","unstructured":"Di Giorgio, A. et al. Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasis. JHEP Rep. 7, 101309 (2025).","journal-title":"JHEP Rep."},{"key":"5422_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5223\/pghn.2025.28.4.245","volume":"28","author":"S Choi","year":"2025","unstructured":"Choi, S. et al. Genetic variants and long-term outcomes in Korean children with progressive familial intrahepatic cholestasis. Pediatr. Gastroenterol. Hepatol. Nutr. 28, 245, https:\/\/doi.org\/10.5223\/pghn.2025.28.4.245 (2025).","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"5422_CR20","volume":"26","author":"P Torfenejad","year":"2016","unstructured":"Torfenejad, P. al. Progressive familial intrahepatic cholestasis and its subtypes: the first report from Iran. Iran. J. Pediatr. 26, e6497 (2016).","journal-title":"Iran. J. Pediatr."},{"key":"5422_CR21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s41436-018-0288-x","volume":"21","author":"S Maddirevula","year":"2019","unstructured":"Maddirevula, S. et al. Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants. Genet. Med. 21, 1164\u201372, https:\/\/doi.org\/10.1038\/s41436-018-0288-x (2019).","journal-title":"Genet. Med."},{"key":"5422_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jpeds.2021.09.019","volume":"240","author":"A Stalke","year":"2022","unstructured":"Stalke, A. et al. KIF12 variants and disturbed hepatocyte polarity in children with a phenotypic spectrum of cholestatic liver disease. J. Pediatr. 240, 284\u201391, https:\/\/doi.org\/10.1016\/j.jpeds.2021.09.019 (2022).","journal-title":"J. Pediatr."},{"key":"5422_CR23","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/s44318-025-00366-8","volume":"44","author":"A Etemad","year":"2025","unstructured":"Etemad, A. et al. Mutations in the kinesin KIF12 promote MASH in humans and mice by disrupting lipogenic enzyme turnover. EMBO J. 44, 1608\u201340, https:\/\/doi.org\/10.1038\/s44318-025-00366-8 (2025).","journal-title":"EMBO J."},{"key":"5422_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2021.100342","volume":"25","author":"P Lipi\u0144ski","year":"2021","unstructured":"Lipi\u0144ski, P. et al. Progressive familial intrahepatic cholestasis type 3: report of four clinical cases, novel ABCB4 variants and long-term follow-up. Ann. Hepatol. 25, 100342. https:\/\/doi.org\/10.1016\/j.aohep.2021.100342 (2021).","journal-title":"Ann. Hepatol."},{"key":"5422_CR25","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1053\/j.gastro.2013.03.053","volume":"144","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield, G. M. et al. The genetics of complex cholestatic disorders. Gastroenterology 144, 1357\u201374, https:\/\/doi.org\/10.1053\/j.gastro.2013.03.053 (2013).","journal-title":"Gastroenterology"},{"key":"5422_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1012825","volume":"10","author":"H Zhu","year":"2022","unstructured":"Zhu, H. et al. Case report: a rare case of young adult progressive familial intrahepatic cholestasis-type 3 with a novel heterozygous pathogenic variant of ABCB4. Front Pediatr. 10, 1012825. https:\/\/doi.org\/10.3389\/fped.2022.1012825 (2022).","journal-title":"Front Pediatr."},{"key":"5422_CR27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00431-018-3181-3","volume":"177","author":"BL Meena","year":"2018","unstructured":"Meena, B. L. et al. Bile duct paucity in childhood\u2014spectrum, profile, and outcome. Eur. J. Pediatr. 177, 1261\u20139, https:\/\/doi.org\/10.1007\/s00431-018-3181-3 (2018).","journal-title":"Eur. J. Pediatr."},{"key":"5422_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0168-8278(01)00158-1","volume":"35","author":"EF Eppens","year":"2001","unstructured":"Eppens, E. F. et al. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J. Hepatol. 35, 436\u201343, https:\/\/doi.org\/10.1016\/S0168-8278(01)00158-1 (2001).","journal-title":"J. Hepatol."},{"key":"5422_CR29","doi-asserted-by":"publisher","first-page":"e0288907","DOI":"10.1371\/journal.pone.0288907","volume":"18","author":"M Ne\u0159oldov\u00e1","year":"2023","unstructured":"Ne\u0159oldov\u00e1, M. et al. Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease. PLoS One 18, e0288907, https:\/\/doi.org\/10.1371\/journal.pone.0288907 (2023).","journal-title":"PLoS One"},{"key":"5422_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000092","volume":"7","author":"ED Pfister","year":"2023","unstructured":"Pfister, E. D. et al. Native liver survival in bile salt export pump deficiency: results of a retrospective cohort study. Hepatol. Commun. 7, e0092. https:\/\/doi.org\/10.1097\/HC9.0000000000000092 (2023).","journal-title":"Hepatol. Commun."},{"key":"5422_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S2468-1253(24)00080-3","volume":"9","author":"AG Miethke","year":"2024","unstructured":"Miethke, A. G. et al. Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Gastroenterol. Hepatol. 9, 620\u201331, https:\/\/doi.org\/10.1016\/S2468-1253(24)00080-3 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"5422_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4254\/wjh.v14.i1.98","volume":"14","author":"S Alam","year":"2022","unstructured":"Alam, S. & Lal, B. B. Recent updates on progressive familial intrahepatic cholestasis types 1, 2 and 3: outcome and therapeutic strategies. World J. Hepatol. 14, 98, https:\/\/doi.org\/10.4254\/wjh.v14.i1.98 (2022).","journal-title":"World J. Hepatol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05422-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05422-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05422-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:04:48Z","timestamp":1789668288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05422-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":32,"alternative-id":["5422"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05422-5","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The research was approved by The Ethics Committee of the Faculty of Medicine \u2013 Alexandria University (16\/2\/2023) in accordance with ICH GCP (International Council for Harmonisation Good Clinical Practice) guidelines with registry number 0107582.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from the guardians of involved cases.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Ethics"}}]}}